Speed to market wont guarantee success in todays launch environment. Anticipating what prescribers, patients and payers will ...

With the wrong architecture in place, AI algorithms can nudge biopharmaceutical developers toward unpredicted and misaligned ...

Biotech is the most honest leadership environment in the world. Science does not soften bad news. Markets do not wait for leaders to feel ready. And the pressure does not lift between a failed trial, ...

As CAR‑T therapy moves beyond traditional ex vivo engineering toward in vivo gene delivery, lentiviral vector (LVV) production faces stricter demands on yield, impurity clearance, scalability, and ...

Canada's medical device regulatory framework has transformed through amendments that fundamentally reshape compliance requirements for MDEL holders. The changes establish new protocols for recall ...

While clinical trial participants provide the essential data that drives medical breakthroughs, the financial systems supporting them remain stuck in the past. Traditional international wire transfers ...

From ancient brewing traditions to cutting-edge pharmaceutical manufacturing, microbial processes have quietly evolved into one of the most transformative forces in modern industry. Today, the same ...

On this week's episode of the Business of Biotech we're speaking with Alan Bash, President, Carvykti, at Legend Biotech, about how Carvykti became a blockbuster, category-leading CAR T therapy for ...

On this week's episode of the Business of Biotech we speak with Dr. Marc Hedrick, M.D., President and CEO at Plus Therapeutics, about the company's pivot from cell therapy to radiotherapeutics for ...

Worldwide Flex is a trusted functional service provider (FSP) and resourcing partner for clinical trials. We deliver best-in-class functional outsourcing services through a variety of models. Whether ...